Cost‐effectiveness of screening for HLA‐A*31:01 prior to initiation of carbamazepine in epilepsy

E-ISSN： 1528-1167|56|4|556-563

ISSN： 0013-9580

Source： EPILEPSIA, Vol.56, Iss.4, 2015-04, pp. : 556-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA‐A*31:01 and HLA‐B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 142-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost Effectiveness of Interferon-Gamma Release Assay for Tuberculosis Screening of Rheumatoid Arthritis Patients prior to Initiation of Tumor Necrosis Factor-α Antagonist Therapy

By Kowada Akiko

Molecular Diagnosis & Therapy, Vol. 14, Iss. 6, 2010-12 ,pp. : 367-373

Adis International

Access to resources Recommend Favorite

Clinical relevance and cost‐effectiveness of HLA genotyping in children with Type 1 diabetes mellitus in screening for coeliac disease in the Netherlands

DIABETIC MEDICINE, Vol. 32, Iss. 6, 2015-06 ,pp. : 834-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of Colorectal Cancer Screening

By Lansdorp-Vogelaar Iris Knudsen Amy B. Brenner Hermann

Epidemiologic Reviews, Vol. 33, Iss. 1, 2011-05 ,pp. : 88-100

Oxford University Press

Access to resources Recommend Favorite

Cost-effectiveness of universal screening for chlamydia and gonorrhea in US jails

By Kraut-Becher Julie Gift Thomas Haddix Anne Irwin Kathleen Greifinger Robert

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 81, Iss. 3, 2004-09 ,pp. : 453-471

Springer Publishing Company

Access to resources Recommend Favorite